Global /United States /Healthcare /Biotechnology /VSBC

VitaSpring Biomedical Co. Ltd.

VSBC

• OTCMKTS: VSBC • Delayed

0.0111USD -96%

As of 14 June 2026, VitaSpring Biomedical Co. Ltd. has a market cap of $2.3M USD, ranking #46885 globally and #5939 in the United States. It ranks #4150 in the Healthcare sector, and #813 in the Biotechnology industry.

Global Rank

46885

Country Rank

5939

Sector Rank

4150

Industry Rank

813

Key Stats

Market Cap

$2.3MUSD

Enterprise Value

$2.4MUSD

EBITDA (TTM)

-$883.36KUSD

Net Income (TTM)

-$895.87KUSD

PB Ratio

-0.6

Company Profile

Country (HQ)

United States

Sector

Healthcare

Industry

Biotechnology

CEO

Ssu-Chuan Lai open_in_new

Founded

2016

Website

vitaspringbio.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
-96%	-	-99%	-99%	-99%	-99%	-93%	-100%	-100%

News

Markets

Exchange	Ticker	Price	Quotes
OTC Markets (OTCMKTS / OTC) MIC: OTCM PRIMARY	VSBC VitaSpring Biomedical Co Ltd Ordinary Shares ISIN: US92851B1026 Shares Out.: Shares Outstanding: 207.03M¹ Shares Float: 97.46M² TV: TradingView: OTC: VSBC SA: Stock Analysis: OTC: VSBC YF: Yahoo Finance: VSBC GF: Google Finance: OTCMKTS: VSBC BA: Barron's: VSBC MS: Morningstar: PINX: VSBC	0.0111 USD	TV: TradingView: OTC: VSBC SA: Stock Analysis: OTC: VSBC YF: Yahoo Finance: VSBC GF: Google Finance: OTCMKTS: VSBC BA: Barron's: VSBC MS: Morningstar: PINX: VSBC

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About VitaSpring Biomedical Co. Ltd.

VitaSpring Biomedical Co. Ltd., a development-stage biomedical company, engages in the research, development, and commercialization of wellness and healthy lifestyle products. The company focuses on the development of cell-based medical technologies for use in regenerative medicine, preventive health care, beauty, and anti-aging applications. It is also involved in the development of cell medical treatment. The company was formerly known as Shemn Corp. and changed its name to VitaSpring Biomedical Co. Ltd. in February 2020. VitaSpring Biomedical Co. Ltd. was incorporated in 2016 and is based in Riverside, California.

Similar Companies

Industry: Biotechnology (United States)

Name	Market Cap (USD) diff.	PE	Country
Amgen Inc. NASDAQ: AMGN	$182.42B 8M%	23.9	United States
Gilead Sciences, Inc. NASDAQ: GILD	$159.92B 7M%	19.0	United States
Natera, Inc. NASDAQ: NTRA	$27.6B 1M%	-	United States
IQVIA Holdings Inc. NYSE: IQV	$26.3B 1M%	20.0	United States
United Therapeutics Corp. NASDAQ: UTHR	$25.03B 1M%	20.4	United States
Moderna, Inc. NASDAQ: MRNA	$18.13B 789K%	-	United States

Industry: Biotechnology (Global)

Name	Market Cap (USD) diff.	PE	Country
argenx SE EBR: ARGX	$47.84B 41.39B EUR 2M%	39.9	Netherlands
Samsung Biologics Co.,Ltd. KRX: 207940	$44.84B 68.19T KRW 2M%	35.5	South Korea
CSL Ltd. ASX: CSL	$42.36B 60.27B AUD 2M%	29.3	Australia
Lonza Group AG SIX: LONN	$42.3B 33.71B CHF 2M%	37.2	Switzerland
Celltrion, Inc. KRX: 068270	$28.11B 42.76T KRW 1M%	43.8	South Korea
BioNTech SE NASDAQ: BNTX	$25.69B 1M%	-	Germany

chevron_leftBack